Healthcare Analytical Testing Services Market Booms, Reaching $41B by 2035

Robust 9.8% CAGR Driven by Outsourcing, Regulatory Demands, and Biologics Innovation

Apr. 6, 2026 at 8:40am

Got story updates? Submit your updates here. ›

The global healthcare analytical testing services market is projected to grow from $16.1 billion in 2025 to $41.0 billion by 2035, registering a robust CAGR of 9.8%. This expansion reflects rising outsourcing of bioanalytical, stability, and microbiological testing as regulatory requirements become more stringent worldwide.

Why it matters

Expansion of healthcare analytical testing services is reinforcing the broader life sciences economy by enabling faster, more compliant drug development and accelerating commercialization timelines for innovative therapies. As pharmaceutical and biotech companies outsource complex assays, they reduce capital expenditure on in-house labs while redirecting investment toward high-value R&D and clinical programs.

The details

Pharmaceutical analytical testing services account for 62.3% of the market, underscoring the importance of impurity profiling, method validation, and raw material testing across complex biologics and small molecules. With North America holding 41.5% share and Asia Pacific expected to post the fastest CAGR, healthcare analytical testing services are becoming a critical backbone for global life sciences innovation, quality assurance, and timely drug approvals.

  • In 2025, the market generated revenue of $16.1 billion.
  • The market is projected to reach $41.0 billion by 2035.

The players

Thermo Fisher Scientific

A leading provider of healthcare analytical testing services, offering a broad range of technologies and expertise to support pharmaceutical, biotech, and medical device companies.

SGS SA

A global testing, inspection, and certification company that provides analytical services for the healthcare industry, with a focus on biosimilar development and advanced characterization.

Charles River Laboratories

A contract research organization that recently expanded its biologics and rapid analytical testing capabilities through the acquisition of PathoQuest SAS, a specialist in next-generation sequencing-based GMP quality-control testing.

LabCorp

A major clinical laboratory and drug development services provider that is building a new, purpose-built central laboratory campus in Indiana to support global clinical trial testing.

Eurofins Scientific

A global network of laboratories that has expanded its US bioanalytical capacity to meet rising demand for biologics and advanced therapy testing, including method development, validation, and routine sample analysis.

Got photos? Submit your photos here. ›

What’s next

Leading providers in this market are scaling geographically distributed lab networks, enhancing throughput and service breadth to support global pharmaceutical, biotech, and device sponsors. They invest heavily in cutting-edge technologies such as high-resolution mass spectrometry, next-generation sequencing, and process analytical technology to deliver faster, more precise results.

The takeaway

The healthcare analytical testing services market is positioned for resilient, innovation-led expansion as regulatory expectations tighten and precision medicine scales globally. Outsourcing remains structurally attractive as sponsors seek flexible capacity and specialized expertise, driving double-digit growth in select subsegments.